First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) Shares Up 0.1% - Here's What Happened

Key Points

• First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation shares rose by 0.1% during trading, valued at GBX 1,501.40 ($20.31) after closing at GBX 1,500.50 ($20.30).
• The stock experienced a significant trading volume increase, with 20,188 shares exchanged, up 183% compared to the average.
• With a market capitalization of £615.90 million and a PE ratio of -1,364.91, the ETF is currently under analysis regarding its buy potential.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report)'s share price rose 0.1% during trading on Thursday . The stock traded as high as GBX 1,506.20 ($20.35) and last traded at GBX 1,501.40 ($20.28). Approximately 20,188 shares traded hands during mid-day trading, an increase of 183% from the average daily volume of 7,135 shares. The stock had previously closed at GBX 1,500.50 ($20.27).

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance

The company has a market capitalization of £648.10 million and a PE ratio of -1,436.27. The stock's fifty day simple moving average is GBX 1,492.63 and its 200-day simple moving average is GBX 1,534.07.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile

Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.